A phenotypic journey into NT5DC proteins in cancer and other diseases

Emeline Cros-Perrial1, Lars Petter Jordheim1

  • 1Université Claude Bernard Lyon 1, INSERM U-1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, 69008, Lyon, France.

Experimental Cell Research
|February 19, 2025
PubMed

Insights

The NT5DC protein family, involved in nucleotide metabolism, shows potential roles in brain diseases. NT5DC2 is a promising drug target for cancer treatment, though further research is needed.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • 5'-nucleotidases are enzymes crucial for nucleotide metabolism, dephosphorylating nucleotide monophosphates.
  • A family of four related proteins, NT5DC1-4, has been identified with growing research interest.
  • Existing literature suggests these proteins may play roles in various cellular processes and disease states.

Purpose of the Study:

  • To review the current scientific literature on the NT5DC protein family.
  • To present available data on the four NT5DC proteins (NT5DC1-4).
  • To discuss the potential involvement of NT5DC proteins in cancer and other diseases, particularly neurological disorders.

Main Methods:

  • Comprehensive literature review of scientific publications on NT5DC proteins.
  • Analysis and synthesis of existing data regarding the function and expression of NT5DC1-4.
  • Discussion of potential therapeutic implications based on current findings.

Main Results:

  • The NT5DC protein family has been increasingly studied in recent years.
  • Evidence suggests a potential role for these proteins in various brain-related diseases.
  • NT5DC2 has emerged as a significant potential drug target in cancer therapy.

Conclusions:

  • The NT5DC protein family's precise role in nucleotide metabolism and purinergic signaling requires further investigation.
  • NT5DC proteins, especially NT5DC2, hold promise as therapeutic targets for cancer.
  • Continued research is essential to fully elucidate the functions and disease relevance of the NT5DC family.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.6K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K